JONES FINANCIAL COMPANIES LLLP

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 815917 DES PERES, MO

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$604,014

+$305,069 QoQ

Shares Held

10,556

+99.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#321

of 561 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

JONES FINANCIAL COMPANIES LLLP holds $339,789,023 across 287 Biotechnology names. BMRN ranks #41 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	215,419	$107,005,079
2	TECH	BIO-TECHNE Corp	797,001	$56,308,120
3	SLS	SELLAS Life Sciences Group, Inc.	2,304,561	$34,015,320
4	ALNY	Alnylam Pharmaceuticals, Inc.	80,491	$24,230,204
5	REGN	Regeneron Pharmaceuticals, Inc.	28,691	$17,889,985
6	ARGX	Argenx SE	14,657	$13,598,324
7	ARDX	Ardelyx, Inc.	1,765,932	$9,006,253
8	INSM	INSMED Inc	68,803	$7,335,774

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$604,014	10,556	+99.5%	Shares	Sole	2026-08-14
2026-03-31	$298,945	5,292	+137.1%	Shares	Sole	2026-05-15
2025-12-31	$132,647	2,232	+59.3%	Shares	Sole	2026-02-17
2025-09-30	$75,878	1,401	+88.1%	Shares	Sole	2025-11-04
2025-06-30	$40,952	745	+22.7%	Shares	Sole	2025-08-13
2025-03-31	$42,908	607	+66.3%	Shares	Sole	2025-05-28
2024-12-31	$23,991	365	+247.6%	Shares	Sole	2025-02-06
2024-09-30	$7,380	105	+23.5%	Shares	Sole	2024-11-12
2024-06-30	$6,998	85	-81.1%	Shares	Sole	2024-08-14
2023-12-31	$43,389	450	+2547.1%	Shares	Sole	2024-02-13
2021-03-31	$1,283	17	-80.5%	Shares	Sole	2021-04-30
2020-12-31	$7,629	87	—	Shares	Sole	2021-02-08
No filing history on record for this holder in this stock.